Abstract：Objective: To study the value of combined detection of urinary insulin-like growth factor binding protein 7 (IGFBP7) and matrix metalloproteinase inhibitor 2 (TIMP-2) in the early risk prediction of severe acute pancreatitis (SAP) complicated with acute kidney injury (AKI). Methods: A total of 89 SAP patients admitted from January 2022 to January 2024 were retrospectively selected. According to the presence or absence of AKI, they were divided into a complicated group (complicated with AKI, 24 cases) and a single group (without AKI, 65 cases). The levels of urinary IGFBP7 and TIMP-2 in the two groups were determined by enzyme-linked immunosorbent assay (ELISA). The influencing factors of AKI in SAP patients were selected by multivariate Logistic regression analysis. The value of the bedside index for severity in acute pancreatitis (Bisap) score and the product of urinary IGFBP7 and TIMP-2 were selected by receiver operating characteristic (ROC) curve analysis. Results: The serum calcium level of the concurrent group was lower than that of the single group, and the product of urinary IGFBP7 and TIMP-2, high-sensitivity C-reactive protein (hs-CRP), procalcitonin (PCT), D-dimer, and Bisap score were higher, and the differences were statistically significant (P<0.05). The product of urinary IGFBP7 and TIMP-2 also increased with the increase of AKI grade in AKI patients (P<0.05). Pearson analysis showed that serum calcium level and urinary IGFBP7 and TIMP-2 product were negatively correlated in AKI patients (P<0.05), and hs-CRP, PCT, D-dimer and Bisap score were positively correlated with TIMP-2 product (P<0.05). Multivariate logistic regression analysis showed that the product of urinary IGFBP7 and TIMP-2 and Bisap score was the influencing factor of SAP complicated with AKI (P<0.05). ROC curve showed that the area under the curve (AUC) of the product of urinary IGFBP7 and TIMP-2 in the prediction of SAP complicated with AKI was higher than that of Bisap score (P<0.05). Conclusion: The significantly increased product of urinary IGFBP7 and TIMP-2 is an influencing factor of AKI in SAP patients and can assist in predicting the occurrence of AKI.
焦念会, 李学军, 亓慧琴, 孙燕洁. 尿TIMP-2与IGFBP7联合检测在预测重症急性胰腺炎并发急性肾损伤早期风险中的价值研究[J]. 河北医学, 2025, 31(5): 766-769.
JIAO Nianhui, LI Xuejun, QI Huiqin, et al. Value of Combined Detection of Urinary TIMP-2 and IGFBP7 in Predicting Early Risk of Acute Kidney Injury Complicating Severe Acute Pancreatitis. HeBei Med, 2025, 31(5): 766-769.
[1] 王健,郁毅刚,林庆斌,等.急性复发性胰腺炎并发急性肾损伤的影响因素分析[J].临床急诊杂志,2023,24(12):637-641. [2] PeyJen Y,Gabriela R,Hugh C,et al.Use of TIMP-2 and IGFBP-7 for prediction of postoperative acute kidney injury after cardiac surgery[J].Clinical nephrology,2022,98(6):288-295. [3] M A C,P L B,Carolyn H.Perioperative urinary TIMP-2*IGFBP7 and acute kidney injury:a systematic review[J].AANA journal,2022,90(3):171-179. [4] 中华医学会消化病学分会胰腺疾病学组.中国急性胰腺炎诊治指南(2013年)[J].中华消化杂志,2013,33(4):217-222. [5] 林珊羽,王飞龙,朱建华.重症急性胰腺炎患者并发急性肾损伤的影响因素分析[J].新医学,2024,55(4):303-310. [6] Schrezenmeier E V,Barasch J,Budde K,et al.Biomarkers in acute kidney injury - pathophysiological basis and clinical performance[J].Acta Physiologica,2017,219(3):554-572. [7] Han H Q,Ou J J,Feng B,et al.Application value of urinary IGFBP7 and TIMP-2 in acute kidney injury with decompensated hepatitis B virus-related liver cirrhosis[J].Zhonghua gan zang bing za zhi=Zhonghua ganzangbing zazhi=Chinese journal of hepatology,2020,28(9):760-765. [8] Moritz S,Martin K,Dominik M A,et al.TIMP-2 and IGFBP7 in human kidney biopsies in renal disease[J].Clinical kidney journal,2023,16(9):1434-1446. [9] 王秋卉,金科,梁锋鸣,等.尿液TIMP-2/IGFBP-7对心脏术后患者早期急性肾损伤的预测价值[J].广东医学,2020,41(17):1796-1799. [10] 于晓燕,赵腾.IL-33在预测重症急性胰腺炎患者发生急性肾损伤的临床效能[J].中国中西医结合肾病杂志,2020,21(1):37-39. [11] 柯尊焕,闫如斌,谷欣荣,等.D二聚体检测在重症急性胰腺炎预后评估中的应用价值[J].血栓与止血学,2022,28(5):724-726.
2025, Vol. 31 
冀公网安备13080202000786号